0000885590-14-000034.txt : 20140430
0000885590-14-000034.hdr.sgml : 20140430
20140430163447
ACCESSION NUMBER: 0000885590-14-000034
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140420
FILED AS OF DATE: 20140430
DATE AS OF CHANGE: 20140430
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Valeant Pharmaceuticals International, Inc.
CENTRAL INDEX KEY: 0000885590
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A8
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2150 ST. ELZEAR BLVD. WEST
STREET 2: LAVAL
CITY: QUEBEC
STATE: A8
ZIP: H7L 4A8
BUSINESS PHONE: 514-744-6792
MAIL ADDRESS:
STREET 1: 2150 ST. ELZEAR BLVD. WEST
STREET 2: LAVAL
CITY: QUEBEC
STATE: A8
ZIP: H7L 4A8
FORMER COMPANY:
FORMER CONFORMED NAME: BIOVAIL Corp
DATE OF NAME CHANGE: 20100416
FORMER COMPANY:
FORMER CONFORMED NAME: BIOVAIL CORP INTERNATIONAL
DATE OF NAME CHANGE: 19960522
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kornwasser Laizer
CENTRAL INDEX KEY: 0001387813
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14956
FILM NUMBER: 14799392
MAIL ADDRESS:
STREET 1: 100 PARSONS POND DRIVE
CITY: FRANKLIN LAKES
STATE: NJ
ZIP: 07417
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2014-04-20
0
0000885590
Valeant Pharmaceuticals International, Inc.
VRX
0001387813
Kornwasser Laizer
400 SOMERSET CORPORATE BLVD
BRIDGEWATER
NJ
08807
0
1
0
0
EVP, Company Group Chairman
Common Stock, no par value
2014-04-20
4
A
0
5017
0
A
58599
D
Common Stock, no par value
2014-04-28
4
F
0
346
122.05
D
58253
D
Common Stock, no par value
2014-04-28
4
M
0
45000
A
103253
D
Common Stock, no par value
2014-04-28
4
F
0
23333
122.05
D
79920
D
Restricted Share Units
2014-04-28
4
M
0
45000
A
Common Stock
45000
45000
D
Represents Restricted Share Units received under an Employee Share Matching Program ("Matching RSUs") in connection with the officer's purchase of Company common stock under a 10b5-1 trading plan. Each Matching RSU represents a contingent right to receive one share of common stock, no par value, of Valeant Pharmaceuticals International, Inc.
1/3 of the Matching RSUs will vest each on the first, second and third anniversary of the date of grant subject to continued employment and retention of the corresponding purchased shares.
This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of Matching Restricted Share Units.
This represents the number of units vested on the performance-based RSUs ("PSUs") that were previously reported on the original Form 4. The initial grant was reported to vest based on total shareholder return (TSR) between a price of $63.86 starting on February 1, 2013 and the average stock price for the 20 trading days starting on each measurement dates: 25% on November 1, 2015, 50% on February 1, 2016 and 25% on May 1, 2016. Unit vesting is contingent on TSR performance between 10% and 30% into between one and three shares of common stock, respectively, with early vesting possible at higher TSR levels. The PSU award may still payout grant value.
This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of Performance Share Units.
by: Nicholas Zanoni for Laizer Kornwasser
2014-04-30